Our Technology Transfer Team guides the translation of early-stage research ideas through the technology development and commercialization process at one of the leading cancer research institutes - Fox Chase Cancer Center. Check out our new technologies available for licensing and industry partnering, and feel free to contact us directly: • List of Technologies https://www.foxchase.org/about-us/research-and-development-alliances/technology-transfer/licensing • Our Team Inna Khartchenko, M.S., MBA, Director (Inna.Khartchenko@fccc.edu) Natalia Shalginskikh, Ph.D., Licensing Associate (Natalia.Shalginskikh@fccc.edu) Tatiana Venkova, Ph.D., Licensing Associate (Tatiana.Venkova@fccc.edu) About Fox Chase Cancer Center: www.foxchase.org The Hospital of Fox Chase Cancer Center and its affiliates (collectively “Fox Chase Cancer Center”), a member of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).